Barong, Julinda R.
HRN: 24-69-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2024
CO-AMOXICLAV 625MG (TAB)
03/15/2024
03/22/2024
PO
625mg
BID
S/P RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes